News from the Center for Emerging Viral Threats

Loading from Vimeo...

One year Anniversary - March 25, 2021

Loading from Vimeo...

Announcement Press Conference - March 25, 2020

Mercury News - The (new) variants look a lot like the virus that was the template of our new bivalent booster, so vaccination still works. “It’s not a perfect match … but it’s close,” said Jeremy Kamil, a virologist at LSUHS, who studies variant mutations. “In most cases, that’s going to keep the infection in check.”

Read More about A stunning 300 new COVID variants are circling the globe. Which ones will break through in the Bay Area?

Bloomberg - Jeremy Kamil, virologist and professor of microbiology and immunology at LSUHS, shares, "Vaccinated and previously infected people have robust and still-intact lines of defense, such as memory T-cells and B-cells. People previously infected also have additional immune cells that reside in the respiratory tract."

Read More about New Covid Variants Have Arrived. How Worried Should You Be? (opens in new window/tab)

318 Forum - The 155,000-square-foot Center for Medical Education will be home to large classroom spaces, clinical skills labs and simulation suites – each designed to encourage collaboration, active engagement and innovative thinking. 

Read More about CENTER FOR MEDICAL EDUCATION: New research, training opportunities (opens in new window/tab)

The Louisiana Board of Regents has supported full five-year approval for the Louisiana Addiction Research Center (LARC) and Center for Emerging Viral Threats (CEVT), with the CEVT continuing to be a designated Center of Research Excellence. The Board of Regents approval follows unanimous approval of both centers by the LSU Board of Supervisors earlier this year. Both centers were previously granted provisional approval and applied for full center approval earlier this year.

Read More about LSUHS Research Centers Receive Full Authorization from LSU Board of Supervisors and Louisiana Board of Regents

The Center of Excellence for Emerging Viral Threats’ (CEVT) Viral Genomics and Surveillance Lab has surpassed uploading its’ 15,000th sequence to GISAID (Global Initiative on Sharing Influenza Data). The LSU Health Shreveport CEVT team has worked tirelessly since early in the COVID-19 pandemic to sequence and track variants of SAR-CoV-2, the virus that causes the COVID-19 disease.

Read More about Center For Emerging Viral Threats Reaches Milestone Of Sharing 15,000 Sars-Cov-2 Sequences To Global Database

NY Times - Opinion - Dr. Jeremy Kamil, ... , shares "As a virologist, it’s important to me that people understand Covid-19 remains a great concern. But this does not excuse or license a misdiagnosis of the current situation."

Read More about I'm a Virologist and I'm Setting the Record Straight on Variants and Reinfection (opens in new window/tab)

Popular Science - The BA.5 wave may not overwhelm hospitals to the degree seen last winter, although emergency rooms and ICUs are already stretched thin. “But there’s definitely going to be an increase to some degree,” says Dr. Jeremy Kamil, a virologist who has led sequencing at LSUHS.

Read More about Omicron variants keep getting better at dodging our immune systems (opens in new window/tab)

Louisiana Senator Bill Cassidy was instrumental in the receipt of this funding for LSUHS, which will enhance the impact of the Center for Emerging Viral Threats (CEVT) as it is able to expand significantly in the new Center for Medical Education building. Additional medical education and research opportunities will yield enhanced economic impact to the region and the state.

Read More about Senator Bill Cassidy Secures $7M Federal Appropriation for LSU Health Shreveport Center for Medical Education and Emerging Viral Threats

NBC News - Scientists have detected a handful of cases of the delta-omicron hybrid but say it's unlikely to cause a new surge. Dr. Jeremy Kamil, an associate professor of microbiology and immunology at LSUHS says, "Delta basically grabbed omicron's spike protein. This is essentially delta trying to hang on by plagiarizing from omicron."

Read More about What is the hybrid 'deltacron' variant of the coronavirus? (opens in new window/tab)

Bloomberg - “No tests can tell you for sure what variant you have without full viral genome sequencing,” says Jeremy Kamil, a microbiologist and immunologist at LSU Health Shreveport. In the U.S., current federal guidance prevents labs from informing patients or their physicians about the specific genome-sequencing results.

Read More about In the U.S., Identifying Your Variant Isn’t So Easy (opens in new window/tab)

New York Times - “Expect the next variant to come out of left field,” said Jeremy Kamil, a virologist at LSU Health Shreveport. He added, “It’d be a hugely foolish thing for anyone to speak with excessive certainty about what’s coming in the next two years.”

Read More about Omicron Offers Hope Pandemic Could Stabilize, W.H.O. Official Says. (opens in new window/tab)

Nature - "Delta has a mutation in the spike gene that reduces some primers’ ability to bind to it, making it harder to sequence this region of the genome. Omicron doesn’t share this mutation, so if any Omicron particles were mixed into the sample owing to contamination, it might make the sequenced spike gene seem to be similar to that in Omicron," says Jeremy Kamil, a virologist at LSUHS.

Read More about Deltacron: the story of the variant that wasn’t (opens in new window/tab)

CEVT News